Solid Tumor Clinical Trials in Sarasota, Florida
4 studies are recruiting for solid tumor in Sarasota, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 effects and safety at various dose levels in an all-comers advanced solid cancer patient population. AGX101will be administered intravenously. Dosing of AGX101 will be re…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Florida Cancer Specialist, Sarasota, Florida
- Locations
- 7 in total
- Run by
- Angiex, Inc.
-
A Study of ASP3082 in Adults With Advanced Solid Tumors
This is an open-label study. This means that people in this study and clinic staff will know that people will receive ASP3082. The study aims to check how safe and well-tolerated ASP3082 is for people with advanced solid tumors that have a specific mutation called KRAS G12D. This study will be in 2…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Florida Cancer Specialists & Research Institute Sarasota, Sarasota, Florida
- Locations
- 66 in total
- Run by
- Astellas Pharma Inc
-
A Study of PYX-201 in Advanced Solid Tumors
The primary objectives of this study are to determine the recommended dose(s) of PYX-201 for participants with recurrent/metastatic (R/M) solid tumors, and to determine the objective response rate (ORR) in participants treated with PYX-201 as a single agent.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- SCRI - Florida Cancer Specialists, Sarasota, Florida
- Locations
- 29 in total
- Run by
- Pyxis Oncology, Inc
-
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
This phase 1 study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of CUSP06 in patients with platinum-refractory/resistant ovarian cancer and other advanced solid tumors.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Florida Cancer Specialists, Sarasota, Florida
- Locations
- 15 in total
- Run by
- OnCusp Therapeutics, Inc.
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.